CVCTU Articles
Advancing blood pressure monitoring with wearable technology
High blood pressure (hypertension) is a leading cause of heart attacks, stroke, and other serious health conditions. Effective blood pressure monitoring is essential for managing hypertension, but traditional cuff-based devices are often inconvenient, uncomfortable, and impractical for continuous tracking.
Date added: Wednesday, June 4, 2025
Novel device shows promise in treating drug-resistant hypertension
High blood pressure (hypertension) remains a significant health challenge globally, affecting over 1.5 billion individuals worldwide. Despite the availability of antihypertensive drugs, a substantial portion of hypertensive patients fail to achieve optimal blood pressure levels, particularly those classified as drug-resistant hypertensive patients. In response to this unmet clinical need, CVCTU is leading SCRATCH-HTN, a groundbreaking study that introduces a novel approach to managing hypertension, potentially revolutionizing treatment for those who have not responded to traditional therapies.
Date added: Wednesday, June 4, 2025
Embracing inclusivity in health research
Many marginalized groups harbour a historical mistrust of health institutions due in large part to systemic discrimination and events like the gross mishandling of the AIDS crisis. This mistrust manifests in avoidance of healthcare services, leading to delayed disease detection and poorer health outcomes.
Date added: Wednesday, June 4, 2025
New study shows inorganic nitrate's potential in protecting kidneys during coronary angiographic procedures
A groundbreaking clinical trial led by Queen Mary University of London, in collaboration with funding from Heart Research UK, has unveiled promising results regarding the use of inorganic nitrate in safeguarding patients against kidney damage during coronary angiographic procedures.
Date added: Wednesday, June 4, 2025
Pioneering cardiovascular research
In the realm of cardiovascular research, the groundbreaking CRAAFT-HF project is capturing the attention of clinicians, researchers, and patients alike. Aimed at demystifying the intersection of atrial fibrillation (AF) and heart failure (HF), this ambitious venture is set to make significant strides in our understanding and management of these intertwined cardiovascular conditions.
Date added: Wednesday, June 4, 2025
Revolutionizing post-operative care with continuous lactate monitoring
Monitoring lactate levels is a critical aspect of post-operative care in cardiac surgery patients. Elevated lactate levels can indicate poor oxygen delivery to tissues, which may lead to complications such as organ failure. Currently, lactate levels are measured intermittently via blood draws, providing only momentary snapshots of a patient’s condition. However, a new non-invasive lactate sensor could transform the way post-operative monitoring is conducted.
Date added: Wednesday, June 4, 2025
Enhancing surgical recovery through continuous lactate monitoring
For patients undergoing cardiac surgery, tracking lactate levels is crucial in assessing post-operative recovery. Elevated lactate can signal potential complications such as oxygen deprivation, tissue damage, or sepsis. Currently, lactate monitoring relies on repeated blood tests, which provide limited real-time data and can be uncomfortable for patients.
Date added: Wednesday, June 4, 2025